Agreed. We are bogged down in long and expensive trials (cancer, NASH, HIV) when sepsis could be fast and potentially well populated, thus cheaper. 1.7m @ 2k would go a long way.

I've noticed that sepsis is becoming relatively common in prosthesis patients with knee, shoulder, hip replacements.